PPT-PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION
Author : jane-oiler | Published Date : 2018-12-14
PhD Viva Seminar Department of Molecular and Clinical Pharmacology University of Liverpool Adeniyi Olagunju Project History Nigerian Map Patients waiting to receive
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION: Transcript
PhD Viva Seminar Department of Molecular and Clinical Pharmacology University of Liverpool Adeniyi Olagunju Project History Nigerian Map Patients waiting to receive a ntiretroviral drugs . CARE. Ana Carolina Maria Araújo Chagas Costa . Lima*. Karine . de Castro . Bezerra*. Deise . Maria do Nascimento . Souza*. Joanna . de Freitas . Rocha*. Mônica . Oliveira Batista . Oriá*. *. Universidade Federal do Ceará (. &. Pharmacogenomics. Personalized Medicine. Drugs and Genes. Pharmacogenetics. : . Study . of the genetic factors that influence an organism's reaction to a drug . Pharmacogenomics: . Development . Missed Opportunities. Ryan White 2012 Conference. Andrew Helfgott, MD. Robert Lawrence, MD. JoNell Potter, PhD, RN. Yvette Rivero, MPH. Workshop Facilitators. Andrew Helfgott, MD . High Risk Obstetrical Services All Children’s Hospital, FL Faculty of Florida / Caribbean AETC. HIV-Free . Survival in Swaziland: A Community-based Household Survey . Dr. Caspian Chouraya: . MD; Dip. HIV Man; MSc (Epidemiology). IAS 2017, Paris, France. STUDY TEAM: . Rhoderick Machekano. 1. , . Agboola Ganiyu Babatunde. 1. , Usman Saheed Opeyemi. 2. , Olubayo Gbemiga Peter. 3. 1. Equitable Health Access Initiative, Department of Clinical laboratory Services. 2. Equitable Health Access Initiative, Department of Community Medicine. HIV. Frederick Morfaw . (Regional Hospital Bamenda Cameroon). . and Jason . Brophy . (. CHEO, . University of Ottawa). 19 July 2016. INTRODUCTION: Global . B. urden of HIV in pregnancy. In 2013, about 16 million of the total 35 million individuals living with HIV globally were women aged 15 years and older, and 3.2 million were children under 15 years of age (UNAIDS 2014).. Jeffrey B. Joy, Richard H. Liang, Rosemary M. McCloskey, Thuy Nguyen, Chanson J. Brumme, Guillaume Colley, Robert S. Hogg, Julio S.G. Montaner, P. Richard Harrigan, and Art F.Y. Poon. Conflict of Interest. (PMTCT). What is PMTCT?. The . transmission of HIV from an HIV-positive mother to her child during pregnancy, . labor. , delivery or breastfeeding is called mother-to-child . transmission (MTCT). . WHO 2011. Idaho Perinatal Project. Feb 19, 2015. Ann J. Melvin MD. Know the epidemiology of HIV infection in women and risk factors for maternal to child transmission. Understand the diagnosis and management of HIV during pregnancy. Willard . Tinago. , . PhD. HIV . Molecular Research Group. UCD School of Medicine. UCD School of Medicine . 3.3 By . 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable . Chloroquine (Aralen) What is chloroquine? Chloroquine (also known as chloroquine phosphate) is an antimalarial medicine. It is available in the United States by prescription only. It is sold (Last updated December 30, 2021; last reviewed December 30, 2021) Panels Recommendations When acute HIV infection is suspected in pregnancy or during breastfeeding, a plasma HIV RNA test should Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection. ). Bhaveen Kalidas. . Daniel . Tharratt. Introduction. Vertical transmission. Vast majority of infections. P. erinatal morbidity and mortality.. PMTCT. What does it entail?. Statistics:. 15% to 45% without treatment.
Download Document
Here is the link to download the presentation.
"PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents